Marcin Protasiewicz
Latest contributions
TAVI in cardiogenic shock
15 May 2024 – From EuroPCR 2024
LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024 – From EuroPCR 2024
This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...
Essentials of lifetime management of TAVI patients
20 Nov 2023 – From PCR London Valves 2023
In this session, discover the key features and benefits of next-generation transcatheter heart valve technology. Gain insights into managing bicuspid and valve-in-valve interventions, and understand the procedural and clinical significance of intermediate and XL sizes in addressing unmet clinical needs.
